Novo Nordisk Stock Surges After FDA Approves Wegovy Pill

Novo Nordisk A/S (NYSE:NVO) shares are trading higher Tuesday following FDA approval of its Wegovy pill.

Novo Nordisk stock is among today’s top performers. Why is NVO stock up today?

What To Know: Novo Nordisk received approval from the U.S. Food and Drug Administration for its GLP-1 pill, marking the first approval of its kind globally.

The company said the pill will launch with a starting dose of 1.5 milligrams and is expected to be available in pharmacies and through select telehealth providers beginning in early January, priced at $149 per month.

Novo Nordisk also said patients paying out of pocket will be able to purchase the pill at the same monthly price through President Donald Trump's direct-to-consumer platform, TrumpRx, under an agreement reached last month.

How To Buy Novo Nordisk Shares

By now you're likely curious about how to participate in the market for Novo Nordisk – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

In the case of Novo Nordisk, which is trading at $48.1 as of publishing time, $100 would buy you 2.08 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

See Also: Eli Lilly Vs. Novo Nordisk: Which Stock Could Lead Pharma’s 2026 Comeback

NVO Price Action: At the time of writing, Novo Nordisk shares are trading 9.71% higher at $52.55, according to data from Benzinga Pro.

Image via Shutterstock